Ease of use to ease your mind 👌. Medable's evidence-generation platform puts seamless user experience at the forefront. Get in touch to find out more here: https://lnkd.in/eKgPjnxx ________ #clinicaltrials #clinicalresearch #healthcare #digitalhealth
About us
Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to making this world a healthier place.
- Website
-
https://www.medable.com
External link for Medable, Inc
- Industry
- Software Development
- Company size
- 501-1,000 employees
- Headquarters
- Palo Alto, CA
- Type
- Privately Held
- Founded
- 2016
- Specialties
- HIPAA, Mobile, API, Platform, Health Tech, PaaS, SaaS, mhealth, eSource, ePro, AI, Machine Learning, Virtual Trials, Clinical Trials, Telemedicine, eConsent, eCOA, Connected Devices, Decentralized trials, and Hybrid trials
Locations
-
Primary
525 University Ave
Palo Alto, CA 94301, US
-
223 S. West Street
Suite 1200
Raleigh, NC 27603, US
Employees at Medable, Inc
Updates
-
Patients deserve equal access to treatments and study opportunities, no matter where they live. Platform technology is the bridge to offering life-changing options to those who need them most 📲 💻. ________ #clinicaltrials #clinicalresearch #healthcare
-
Get to know the people across Medable, united on one mission to get effective therapies to patients faster! The newest edition of Medable Stories features Julien Verfaillie - a powerhouse on our Engineering team. Find out a few of his aspirations, areas of expertise, & favorite hobbies below 🔽: ________ #clinicalresearch #clinicalresearch #healthcare #digitalhealth
-
Medable, Inc reposted this
A few weeks ago, the FDA released the draft Diversity Action Plan (DAP) guidance following the introduction of Diversity Action Plans in the Food and Drug Omnibus Reform Act of 2022 (FDORA) consolidating the legal mandate for representative clinical trial populations in clinical trials. Earlier, The Oncology Center of Excellence (OCE) released an internal review -Project Equity- that analyzed the first year (April 2022-April 2023) of DAPs submitted post FDORA. 91 DAPs were submitted to CDER, 86% to OCE representing 42 sponsors. Only 6% were deemed acceptable; with enrollment goals being the topic (90%) most addressed in FDA feedback. Measures to achieve the diversity plan represented 29% of feedback. Clinical trials aim to gather efficacy and safety data from the intended user population of a medical product. Historically, they have failed to enroll representative populations, hindering informed decision-making. The guidance on diversity action plans describes how you can calculate the population make-up of your trial and requires a rationale for your decision, and require specificity on the measures to achieve diversity goals. Different measures can be taken to achieve enrolling representative populations. #Sites play an important role in achieving the diversity enrollment goals and are partners in achieving diversity. Community engagement, patient facing clinical trial documents in different languages and eConsent are mentioned in Washington State’s Diversity in Clinical Trials Bill. Project Equity found the most common measures to be participant facing measures, community engagement, workforce considerations, eligibility criteria and decentralized elements. 20% of the DAPs submitted between April 2022 and 2023 per Project Equity included DCT elements as a measure. The Tufts CSDD PACT consortium’s first data readout shows emerging data to suggest a trend of increased diversity using DCT elements. While this is very preliminary data, it is exciting that DCT elements are now an (emerging) evidence based measure/solution to achieve diversity. Medable, Inc Michelle Longmire Alison Holland
-
"Diversity in clinical trials is crucial to ensuring the enrolled patients mirror the intended population." Hear what Industry leaders from Tufts Center for the Study of Drug Development and Medable, Inc have to say about the positive impacts that digital trial methodologies could have on patient inclusion and representation 🌍. Read here: https://lnkd.in/e62MAytP ________ Pamela Tenaerts, MD, MBA, Ken Getz, The Clinical Trial Vanguard #clinicaltrials #clinicalresearch #healthcare #diversity
Decentralized Clinical Trials: A New Era of Diversity
https://www.clinicaltrialvanguard.com
-
The question is no longer, "What if patients were involved in planning clinical trials?" The question now is, "What more can we do to involve them?" 🤝 View this on-demand webinar to find out why trial designs that incorporate learnings from lived patient and caregiver experiences are the most effective. Uncover how leveraging patient-centric insights and eCOA technologies in your studies can: - Enhance data quality. - Empower patient diversity. - Foster greater retention. Watch here: https://lnkd.in/e3UwMfUb ________ #clinicaltrials #clinicalresearch #healthcare #digitalhealth
Optimizing Digital Evidence Generation Using the Patient's Lens | Medable
medable.com
-
In today’s research landscape, email remains an indispensable ally in clinical trials, offering efficiency, reach, and adherence. Embracing this digital gold standard ensures effective communication, successful participant recruitment, engagement, and retention, ultimately contributing to the advancement of healthcare globally 💻 . Learn more here: https://lnkd.in/eK7eRutq ________ #clinicaltrials #clinicalresearch #healthcare #email
-
Industry-leading adherence 🤝 Industry-leading results Help patients stay connected to sites during some of the hardest times in their lives. ________ #clinicaltrials #clinicalresearch #healthcare #digitalhealth
-
As clinical trials continue their focus on rare diseases and disease subtypes, biospecimen storage and their consent will remain critical. Organizations should strongly consider eConsent technology, like Total Consent, to unlock the full potential of biospecimen research while maintaining the highest standards of regulatory compliance and ethical conduct. Learn more here: https://lnkd.in/eSAEmfDm ________ #clinicalresearch #clinicaltrials #healthcare #digitalhealth
-
Uncover the power of patient-level datasets! Watch this on-demand panel where leaders from GSK, Moderna, & Medable share best practices for using fully-consented patient data in clinical trials. Explore the game-changing impacts of value-driven data & digital healthcare 📲. View here: https://lnkd.in/en72-aqe ________ #clinicaltrials #clinicalresearch #healthcare
Panel Discussion: Harnessing the Potential of Patient-Level data in Clinical Trials | Medable
medable.com